Home | Sitemap | Contact Us

Home > About us > Who we are > Board
Board

 

Prof. Jean-Louis Vincent, Brussels, Belgium (President)

 

jmDr. Vincent is Professor of intensive care medicine at the University of Brussels and intensivist in the Department of Intensive Care at the Erasme University Hospital in Brussels. A specialist in Internal Medicine, he spent two years training at the University of Southern California with Prof. Max Harry Weil. Dr. Vincent has signed more than 800 original articles, some 300 book chapters and review articles, and 850 original abstracts, and has edited 86 books. He is co-editor of the Textbook of Critical Care and the “Encyclopedia of Intensive Care Medicine”.
Dr. Vincent is the editor-in-chief of "Critical Care", "Current Opinion in Critical Care", and "ICU Management". He is member of the Editorial Boards of some 30 journals, and has organized the annual International Symposium on Intensive Care and Emergency Medicine for 35 years.
Dr. Vincent is presently President of the World Federation of Societies of Intensive and Critical Care Medicine. He is a Past-President of the Belgian Society of Intensive Care Medicine, the European Society of Intensive Care Medicine, the European Shock Society, and the International Sepsis Forum.
He has received the Distinguished Investigator Award of the Society of Critical Care Medicine, the College Medalist Award of the American College of Chest Physicians, was the Recipient of the "Society Medal” (lifetime award) of the European Society of Intensive Care Medicine and has received the prestigious Joseph-Maisin Clinical Biomedical Sciences Prize awarded by the Belgian Fund for Scientific Research.

 

Dr. Jörg Rustige, Bad Homburg, Germany (Vice-President)

jr

Joerg Rustige graduated from Steinbart-Gymnasium, Duisburg in 1965 and studied physics at the University of Kiel and Hamburg, Germany. In his post-graduate work at DESY, Hamburg he researched synchrotron physics and computer simulation of electron trajectories enabling electron beam quality and ejection fraction to be optimised.


From 1973, he went to Medical School in Hamburg and Münster, Germany. He acquired his doctorate degree in the field of psychiatry, working with patients suffering from depression.


His further work brought him to the University of Aachen, where he was involved in early research in thrombolysis, pacemaker controls and atrial fibrillation. As a Senior Resident in Ludwigshafen, working in a Teaching Hospital of the University of Mainz, he introduced primary angioplasty in 1993, and documented time delays for the treatment of heart attacks in 153 German hospitals, while also laying the foundation for observational studies in the field of Cardiology.


Since 1996, he has been working on clinical studies involving platelet inhibition, leading the research laboratories of Eli Lilly in Canada, and on later cardiovascular research in Europe. He recently retired from his role as Vice-President of Medical Affairs with Correvio International Sarl located in Geneva, Switzerland.

 

Prof Dr. Dan Lon
jm
grois, Paris, France

 

Dan Longrois was born Romania and is a French citizen. He obtained his medical degree from the Faculté de Médcine Paris VI, at the Pierre et Marie Curie University in Paris. After qualifying in anaesthesia and intensive care, he served as a Research Fellow in the Cardiovascular Division at the Brigham and Women's Hospital, Harvard Medical School in Boston, USA. In 1996, he obtained his Ph.D. in cardiovascular pharmacology at the Pierre and Marie Curie University in Paris. He was Professor of Anaesthesia and Intensive Care at the Medical Faculty of the Henri Poincaré University of Nancy, France. He was Head of the two Anaesthesia and Intensive Care Departments of the academic hospital of Nancy, and he is presently Professor of Anaesthesia and Intensive Care in Bicha-Claude Bernard Hospital in Paris. He is also a member if the INSERM 1148 unit in Paris.

 

His research interests include the regulation of the inflammatory response in cardiovascular diseases. Prof Longrois was a member of the Scientific Committee of the French Society of Anaesthesia and Intensive Care, and a member of the Medical and Scientific Committee of the French ‘Agence de la Biomédecine’. He currently presides over the French College of Perfusion. He is presently a member of the Board of Directors of the European Society of Anaesthesiology and is Chairperson of the National Anaesthesiologists Societies Committee. He has contributed more than 150 scientific publications and authored several book chapters on cardiovascular pharmacology and physiopathology related to anaesthesia and intensive care.

 

Prof Longrois has contributed to the design, conduct and steering of several clinical trials in anaesthesia, intensive care and cardiology. He has served as member of Endpoint Committees and Data and Safety Monitoring Boards for several trials in the fields of anaesthesia, intensive care and cardiology.

 

Prof. Peter Rimensberger, Geneva, Switzerlandpb

 

Prof. Peter Rimensberger is Head of Paediatric and Neonatal Intensive Care at the University Hospital of Geneva, and is Past Medical President of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). He has authored more than 100 publications with a main focus on paediatric and neonatal ventilation, and is editor of a textbook on Paediatric and Neonatal ventilation. He is a regular speaker at neonatal, paediatric and adult intensive care meetings, and organizer of regular hands-on workshops worldwide.

 

Prof. John Martin, London, United Kingdom (Past President)
jm

Dr John Martin is Director of the Centre for Cardiovascular Biology andMedicine at University College London, Adjunct Professor of Internal Medicine at Yale and Co-Director of the Yale-UCL Collaborative. He studied philosophy in Spain before qualifying from Sheffield University Medical School in 1973. He became a senior lecturer at Melbourne University, Australia where he began his research into platelet formation. His research interest in platelet biology on pathophysiology continues, and he has been involved in the novel role of VEGF as an arterio-protective agent. His discoveries from research into vascular endothelial growth factor have been patented and he co-founded a biotechnology company which is listed on the London Stock Exchange.


John Martin wrote the "Heart Plan for Europe ", which gave rise to a statement from the Council of Ministers of the European Union in June 2002 and was instrumental in developing the ground-breaking European Heart Health Charter in 2007. He was awarded the Gold Medal of the European Society of Cardiology for his work.


Professor Martin holds a number of honorary and advisory posts on medical and scientific issues. He is an accomplished linguist, poet and public speaker, with a deep interest in philosophy and European affairs.


Board Nominees

Prof George Crooks, Aberdeen, Scotland

jm

Prof Crooks is currently the Medical Director for NHS 24 and Director of the Scottish Centre for Telehealth & Telecare. NHS 24 is the national provider of telehealth services for the whole of Scotland currently providing the majority of its services via telephony, the web and digital television. He is responsible for the quality, safety and effectiveness of all clinical services, the development of new services in partnership with other NHS organisations, and leading information governance, business continuity and emergency planning. Prof Crooks has a particular interest in the field of unscheduled care, including the development of common assessment and triage processes across the NHS and use of technology to support the delivery of high quality patient care to the population of Scotland.

 

George Crooks was a General Medical Practitioner for 23 years in Aberdeen latterly combining that role as Director of Primary Care for Grampian. He was elected President of the European Health Telematics Association in February 2012 and is a Board member of the European Connected Health Alliance. He leads the Integrated Care Action Group on behalf of the European Commission within the European Partnership for Active and Healthy Ageing. He is Chair of the Scottish Digital Health and Care Innovation Programme Board, leading on the at scale delivery of telehealth and telecare services and also the Chairman of the Digital Health Institute in Scotland, a partnership between academia, industry and health and care delivery organisations delivering innovation in technology and design that can provide safe, effective and sustainable health and care solutions and create economic growth in Scotland.

 

He was awarded an OBE in the Queen’s New Year Honours List 2011 for services to healthcare.

 

Prof. Michael Quintel, Göttingen, Germany
pb

 

Prof. Dr. Quintel serves as the Director of the Department of Anaesthesiology, Emergency and Intensive Care Medicine at the University of Göttingen, Germany. Prof. Quintel is a leading clinician within the German and European intensive care profession. He served as President of the German Interdisciplinary Society of Intensive Care Medicine (DIVI). Prof. Quintel has been a Member of Medical Advisory Board at Sphere Medical Holding PLC since December 11, 2014. He is a Member of the European Society of Intensive Care Medicine (ESICM) group on respiratory failure, a Member of the Scientific Committee of International ECMONet.

 

He served as a Council Member of the German Society of Anaesthesia and Intensive Care (DGAI). He is a Member of the German Sepsis Society and an Investigator in the SepNet Sepsis Clinical Trial Network in Germany and has participated in numerous sepsis and critical care trials.

 

 

 

 

 

 


© ECCF, 100 rue du Rhône, 1211 Geneva, Switzerland
Privacy